Divis Laboratories Ltd reported 40M in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2024
Aurobindo Pharma INR 82.63B 1.64B Mar/2025
Avita Medical AUD 45.98M 895K Dec/2024
Dianthus Therapeutics USD 1.33M 161K Jun/2025
Divis Laboratories Ltd 40M 40M Mar/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
IQVIA Holdings USD 15.49B 1.16B Jun/2025
Lupin INR 54.48B 20.05B Mar/2025
Moderna USD 741M 4M Jun/2025
Organon & Co USD 8.9B 60M Jun/2025
Revvity USD 3.17B 17.91M Mar/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Tilray USD 351.72M 15.26M Nov/2024
Viatris USD 14.76B 580.1M Jun/2025
Xeris Pharmaceuticals USD 257.22M 10.01M Jun/2025